Tower Research Capital (TRC)’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17K Buy
2,923
+1,339
+85% +$9.1K ﹤0.01% 3894
2026
Q2
$10.5K Buy
+1,584
New +$10.6K ﹤0.01% 3976
2025
Q4
– Sell
-365
Closed -$1.78K – 5487
2025
Q3
$1.78K Buy
+365
New +$1.86K ﹤0.01% 4732
2025
Q1
– Sell
-316
Closed -$2.37K – 5656
2024
Q4
$2.37K Buy
+316
New +$2.43K ﹤0.01% 4855
2024
Q2
– Sell
-103
Closed -$879 – 5940
2024
Q1
$879 Sell
103
-312
-75% -$2.6K ﹤0.01% 5368
2023
Q4
$3.52K Buy
+415
New +$3.94K ﹤0.01% 5069
2023
Q3
– Sell
-3,004
Closed -$39.1K – 6167
2023
Q2
$39.1K Buy
3,004
+2,688
+851% +$33.3K ﹤0.01% 2791
2023
Q1
$3K Buy
+316
New +$3.66K ﹤0.01% 5227
2022
Q4
– Sell
-3,100
Closed -$13K – 6259
2022
Q3
$13K Buy
3,100
+1,047
+51% +$7.07K ﹤0.01% 4281
2022
Q2
$15K Buy
2,053
+1,917
+1,410% +$15.2K ﹤0.01% 4086
2022
Q1
$1K Sell
136
-127
-48% -$1.22K ﹤0.01% 5840
2021
Q4
$3K Buy
+263
New +$3.28K ﹤0.01% 5477
2021
Q3
– Sell
-530
Closed -$9K – 6076
2021
Q2
$9K Buy
530
+473
+830% +$8.8K ﹤0.01% 4445
2021
Q1
$1K Buy
+57
New +$1.37K ﹤0.01% 5204

Other funds holding PROF

Tower Research Capital (TRC)'s PROF Position: Q3 2026 in Review

Tower Research Capital (TRC) increased its Profound Medical (PROF) stake by 85% in Q3 2026, buying an estimated $9.1K and bringing the position to 2,923 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #3894.

Tower Research Capital (TRC) first reported a position in PROF in Q1 2021 and has held it in 14 quarters since. The position peaked at $39.1K in Q2 2023. 57 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Tower Research Capital (TRC) held 2,923 shares of Profound Medical worth $17K as of Q3 2026.
  • Tower Research Capital (TRC) bought 1,339 Profound Medical shares in Q3 2026, an estimated $9.1K.
  • Profound Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3894 holding.
  • Tower Research Capital (TRC) first reported a position in Profound Medical in Q1 2021 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s Profound Medical position peaked at $39.1K in Q2 2023.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.